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Abstract
Omega-3 polyunsaturated fatty acids (omega-3 PUFAs) play a role in controlling pathological inflammatory reactions.
Endometriosis is characterized by the presence of endometrial tissue on the peritoneum and an exaggerated inflammatory
environment around ectopic tissues. Here peritoneal endometriosis was reproduced using a mouse model in which murine
endometrial fragments were inoculated into the peritoneal cavity of mice. Fat-1 mice, in which omega-6 can be converted
to omega-3 PUFAs, or wild type mice, in which it cannot, were used for the endometriosis model to address the actions of
omega-3 PUFAs on the development of endometriotic lesions. The number and weight of cystic endometriotic lesions in
fat-1 mice two weeks after inoculation were significantly less than half to those of controls. Mediator lipidomics revealed
that cystic endometriotic lesions and peritoneal fluids were abundant in 12/15-hydroxyeicosapentaenoic acid (12/15-HEPE),
derived from eicosapentaenoic acid (EPA), and their amount in fat-1 mice was significantly larger than that in controls. 12/
15-Lipoxygenase (12/15-LOX)-knockout (KO) and control mice with or without EPA administration were assessed for the
endometriosis model. EPA administration decreased the number of lesions in controls but not in 12/15-LOX-KO mice. The
peritoneal fluids in EPA-fed 12/15-LOX-KO mice contained reduced levels of EPA metabolites such as 12/15-HEPE and EPA-
derived resolvin E3 even after EPA administration. cDNA microarrays of endometriotic lesions revealed that Interleukin-6 (IL-
6) expression in fat-1 mice was significantly lower than that in controls. These results suggest that both endogenous and
exogenous EPA-derived PUFAs protect against the development of endometriosis through their anti-inflammatory effects
and, in particular, the 12/15-LOX-pathway products of EPA may be key mediators to suppress endometriosis.
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Introduction
Eicosapentaenoic acid (EPA, C20:5n-3) and Docosahexaenoic
acid (DHA, C22:6n-3) are representative omega-3 polyunsaturat-
ed fatty acids (PUFAs) and show anti-inflammatory effects in acute
and chronic inflammatory conditions [1]. Increased levels of
omega-3 PUFAs in a tissue lead to the formation of functional
EPA or DHA-derived mediators, such as resolvins and protectins,
and protects from tissue damage [2]. Many studies have been
focused on their effect in resolving inflammation mostly through
reductions in neutrophil trafficking and upregulation of macro-
phage-mediated removal of apoptotic cells [3]. This is associated
with attenuated pro-inflammatory signaling by Leukotriene B4
Receptor 1 (BLT1) and ChemR23, which are expressed on
neutrophils and macrophages [4,5], respectively, and decreased
activity of the pro-inflammatory transcription factor nuclear factor
kappa beta (NF-kB) [6,7].
Dietary supplementation is a traditional approach to modify
tissue nutrient composition in animal studies of nutrition. Feeding
animals different diets that consist of many components derived
from different materials can cause many variations between
experimental groups. Kang et al. recently engineered a transgenic
mouse that carries the fat-1 gene from the roundworm
Caenorhabditis elegans [8]. This gene encodes an omega-3 fatty acid
desaturase that catalyzes conversion of omega-6 to omega-3
PUFAs and that is absent in most animals, including mammals.
There is a remarkable difference in the tissue omega-6/omega-3
PUFA ratio between wild type and fat-1 transgenic mice [9]. Fat-1
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.mice, which can have an altered ratio of omega-6 to omega-3
PUFAs in their tissues and organs independent of diet, allow
carefully controlled studies to be performed in the absence of
potential confounding factors of diet and, therefore, are a useful
model to investigate the biological properties of endogenous
omega-3 PUFAs [8].
Endometriosis is one of the most common gynecological
disorders and is a chronic condition characterized by the presence
of endometrial tissue outside the uterine cavity, most commonly on
the pelvic peritoneum and ovaries. The disease can involve
adjacent organs such as the fallopian tubes, bladder, and recto-
sigmoid colon. Endometriosis has a prevalence of up to 50%
among infertile women and is associated with various distressing
symptoms, including dysmenorrhea, pelvic pain, and infertility
[10]. These symptoms are thought to be the result of an excessive
inflammatory environment within the peritoneal cavity. Numerous
studies support that elevated numbers of activated immune cells,
particularly peritoneal macrophages, are involved in the molecular
and cellular processes that lead to endometriotic lesion develop-
ment; initiation, maintenance, and progression of endometriotic
lesions [11]. Peritoneal macrophages are known to express
inflammatory cytokines, such as IL-6, IL-1b and tumor necrosis
factor alpha (TNF-a) [12–14] and to be increased in number and
more activated in patients with endometriosis [15]. Ectopic
endometrial tissues in the peritoneum not only express proin-
flammatory cytokines in a dysregulated manner, but also elicit
aberrant immune influencing factors in the peritoneal fluid,
creating a local inflammatory environment [16]. These include
prostaglandins (PGs), IL-8 and monocyte chemotactic peptide 1
(MCP-1). IL-8 levels are elevated in the peritoneal fluid of women
with endometriosis and levels have been correlated with the
severity of the disease [17]. Many studies demonstrated that iron
overload originates from lysis of pelvic erythrocytes accumulated
by retrograde menstruation and induces oxidative stress in the
pelvic cavity. Iron storage levels are higher in the peritoneal
macrophages of endometriosis patients than those of controls [18].
Oxidative stress promotes the NF-kB pathway as well as DNA
damage. NF-kB-activated macrophages express proinflammatory,
growth, and angiogenic factors, such as inducible Nitric Oxide
(iNOS), cyclooxygenase-2 (COX-2), IL-1, IL-6, IL-8, TNF-a, and
vascular endothelial growth factor (VEGF), which contribute to
endometriosis pathogenesis and possible carcinogenesis [19].
Many laboratories have established a variety of experimental
animal models of endometriosis, in which endometriotic lesions
develop in the peritoneum of small animals, such as the rabbit, rat,
and mouse[20–24]. These models use homologous or heterologous
endometria obtained from congenic animal or human specimens,
respectively, as an inoculant into the animal peritoneum. As one of
heterologous models, the severe immunodeficient (SCID) mouse is
used as a recipient animal and then the model is unsuitable for
experiments to investigate immune responses or immunomodula-
tory effects in endometriotic lesions [25]. We established the
homologous model in which the uterus of immunologically normal
C57BL/6 strain mice was minced and injected into the peritoneal
cavity of the same strain mice [21]. In this model, recipient mice
develop endometriotic lesions at the peritoneum, omentum,
perivisceral fat tissue, intestinal, and uterine surface. These lesions
progress more in mice exposed to estradiol after inoculation of
endometrial fragments than that with non-exposed mice, indicat-
ing that our model mimics endometriosis in human.
Viewing the important impact of omega-3 PUFAs on patho-
logical inflammatory reactions, we hypothesized that omega-3
PUFAs exhibit a protective action on the chronic inflammatory
condition of endometriosis. In this study, fat-1 mice were utilized
to address the biological properties of omega-3 PUFAs in the
homologous model of endometriosis. We here demonstrated that
the endogenous production of omega-3 PUFAs and exogenous
EPA affords protection against the development of peritoneal
endometriotic lesions.
Materials and Methods
Animals and Diets
Fat-1 mice were created on a C57BL/6 background and
heterozygote as described [9] and subsequently backcrossed (at
least four times) onto a C57BL/6 background. 12/15-LOX-KO
mice on a C57BL/6 background were obtained from The Jackson
Laboratory (Bar Harbor, ME). Animals were fed a special diet
(AIN-76A+10% safflower oil; CLEA Japan, Inc.) that contained
10.3% total fat with fatty acid composition of C16:0 (7.6%), C18:0
(2.7%), C18:1n-9 (14.1%), C18:2n-6 (73.2%), C18: 3n-3 (0.3%),
C20:4n-6 (,0.1%), C20:5n-3 (,0.1%), C22: 6n-3 (,0.1%), high
in n-6 and low in n-3 fatty acids, until the desired age (6–8 weeks)
for experiments. EPA was administered by the addition of 5%
EPA ethyl ester (kindly provided by Mochida Pharmaceutical Co.,
Ltd. Japan) in the fish meal-free F1 diet (Funabashi farm Co., Ltd.
Japan) that contained 4.4% total fat with fatty acid composition of
C16:0 (14.9%), C18:0 (5.0%), C18:1n-9 (20.8%), C18:2n-6
(52.4%), C18:3n-3 (4.9%), C20:4n-6 (,0.1%), C20:5n-3
(,0.1%), C22:6n-3 (,0.1%). To prevent the oxidation of lipids,
all diet was stored in the refrigerator with antioxidants (AGELESS;
Mitsubishi Gas Chemical Inc.), and prepared newly every
two days. Animal studies were approved by the University of
Tokyo Animal Committee.
Endometriosis model in mice
Both donor and recipient mice, 6–8 weeks old, were ovariec-
tomized to remove the effects of endogenous hormonal changes.
All donor mice and recipient mice were injected s.c. with 100 mg/
kg estradiol depot (ASKA Pharmaceutical Co., Ltd, Tokyo, Japan)
in corn oil every week from the time of the ovariectomy.
Two weeks after the ovariectomy, donor mice were killed by
cervical dislocation. Uterine horns were removed and put into a
dish containing phosphate-buffered saline (PBS). Endometrial
fragments, obtained by peeling off the serosa and myometrium
gently, were minced using a razor blade. Fragments suspended in
0.6 ml PBS were injected with an 18-gauge needle through the
abdominal wall just below the umbilicus into the peritoneal cavity
of recipient mice with a ratio of one donor to two recipients. Fat-1,
12/15-LOX-KO, or littermate wild type mice were used as both
donor and recipient mice for each group. Four mice for each
group were sacrificed two weeks after the injection and peritoneal
endometriotic lesions and peritoneal washes were collected.
Evaluation of peritoneal lesions
Peritoneal lesions forming a cystic lesion were covered with
surrounding stromal cells histologically, backed by endometrial
cells, and showed much more at the omentum, pelvic cavity,
mesenterium and diaphragm. After counting the number of cystic
lesions, they were completely excised, fixed with 2% Paraformal-
dehyd (PFA) + PBS (WAKO, Osaka, Japan), and embedded in
paraffin. Serial sections were cut at 8 mm thickness on a cryostat
and mounted on poly-L-lysine-treated slides. They were stained
with hematoxylin-eosin (HE) and observed under microscopy
(BX50; Olympus, Japan). The histological diagnosis of endome-
triosis was based on the morphological identification of endome-
triotic glands and stroma. The weight of endometriotic lesions was
measured.
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LC-MS/MS-based mediator lipidomics was performed as
described previously [26]. Briefly, samples were extracted by
solid-phase extraction using Sep-Pak C18 cartridges (Waters,
Milford, MA, USA) with deuterium-labeled internal standards
(PGE2-d4, LTB4-d4, 15-HETE-d8, arachidonic acid-d8). LC-MS/
MS-based lipidomic analyses are performed on Acquity UPLC
BEH C18 column (1.0 mm6150 mm61.7 mm) using Acquity
UltraPerformance LC system (Waters Co.) coupled to an electro-
spray (ESI) triple quadrupole mass spectrometer (QTRAP5500; AB
SCIEX). The MS/MS analyses were performed in negative ion
mode, and the eicosanoids and docosanoids were identified and
quantified by multiple reaction monitoring. Calibration curves
between 1 and 1000 pg and the LC retention times for each
compounds were constructed with synthetic standards.
cDNA Microarray
We collected cystic lesions 2 weeks after injection of minced
endometrium, and total RNA was extracted from their lesions.
they were incubated in RNA later. For the cDNA microarray
analysis, 0.5 mg of pooled total RNA was amplified and labeled
using an Amino Allyl MessageAmpTM II aRNA Amplification kit
(Applied Biosystems, Foster City, CA, USA) according to the
manufacturer’s instructions. Each sample of aRNA labeled with
Cy3 and reference aRNA labeled with Cy5 was cohybridized with
GeneTM Mouse Oligo chip 24 k (Toray Industries Inc., Tokyo,
Japan) at 37uC for 16 h. After hybridization, each DNA chip was
washed and dried. Hybridization signals derived from Cy3 and
Cy5 were scanned using Scan Array Express (PerkinElmer,
Waltham, MA, USA). The scanned image was analyzed using
GenePix Pro (MDS Analytical Technologies, Sunnyvale, CA,
USA). All analyzed data were scaled by global normalization.
RT-PCR for peritoneal macrophages
After washing the peritoneal cavity of each mouse with 5 ml PBS,
peritoneal washes were filtered through a 30 mms t r a i n e ra n d
centrifugedfor5 minat200 g.Fromrecoveredcellularcomponents,
CD11b-positivemacrophageswereisolatedusinganisolationkitand
incubated in RNA later. We isolated RNA from these macrophages
after homogenizing. Two mg of total RNA was extracted using an
RNeasy Mini Kit (Qiagen, Hilden, Germany), followed by reverse
transcription. We amplified cDNA for 40 cycles with a Light Cycler
480 (Roche, Basel, Switzerland) using a Universal Probe Master and
the following primers and Universal Probe Library (UPL) probes
(Roche): Interleukin-6 (IL-6) Forward (gctaccaaactggatataatcagga)
and Reverse (ccaggtagctatggtactccagaa), with the UPL Probe #6
and b-actin (ACTB) Forward (ctaaggccaaccgtgaaaag) and Reverse
(accagaggcatacagggaca), with the UPL Probe #64. We calculated
expression levels by the comparative CT method using b-actin as an
endogenous reference gene.
Statistical Analysis
Results were expressed as mean 6 standard error. Comparisons
between the two groups were performed using the Mann-Whitney
U test. Comparisons between multi-groups were performed using
the Tukey-Kramer post hoc multiple comparisons test.
Results
Comparison of endometriotic lesions between fat-1 and
wild type mice
Fat-1 and littermate wild type mice were fed with a diet
enriched in omega-6 PUFAs. Omega-6 PUFAs are converted into
omega-3 PUFAs by fat-1, C. elegans n-3 fatty acid desaturase, in fat-
1 mice. The high omega-6 diet led to wide differences in fatty acid
profiles, i.e. low (fat-1) vs. high (wild type) omega-6/omega-3 ratios
in a litter of mice born to the same mother. We then generated the
homologous endometriosis model in which the uterus of fat-1 or
wild type mice was minced and injected into the peritoneal cavity
of fat-1 or wild type mice, respectively. The AA/EPA + DHA ratio
of uterine tissues from the fat-1 mice was 0.82 and from the wild
type mice was 2.14. Endometrial fragments were incubated in the
peritoneal cavity of mice for two weeks with estrogen treatment.
After incubation, mice were sacrificed and the whole peritoneal
cavity was examined carefully. Both fat-1 and wild type mice had a
scattering of approximately 2–5 mm of cystic mass on the
peritoneum. The number of cystic lesions was counted macro-
scopically and the cystic mass was resected separately for
evaluation of the weight. A comparison was made for the number
and weight of endometriotic lesions between fat-1 and wild type
mice (n=10 in each group) (Fig. 1). The cystic mass, composed of
monolayer columnar epithelia and endometrial stroma, was
histologically diagnosed as an endometrial cyst (data not shown).
In fat-1 mice, the number of lesions was fewer than half and the
weight per lesion was less than half that of wild type mice,
indicating that the development of cystic endometriotic lesions
were dramatically reduced in fat-1 mice.
Lipidomics of endometriotic lesions in fat-1 and wild
type mice
Fat-1 mice showed a decreased number and weight of cystic
endometriotic lesions suggesting that increased omega-3 PUFAs
are associated with the suppression of endometriosis. To address
the mechanisms involved in this suppressive effect, LC-MS/MS-
based lipidomic analyses were performed to monitor lipid
mediators derived from omega-3 as well as omega-6 PUFAs
[26]. First, the endometriotic lesion was examined by lipidomic
analyses and a direct comparison was made for PUFA metabolites
between fat-1 and wild type mice (n=3 in each group) (Fig. 2). A
Figure 1. Development of endometriotic lesions in fat-1 and
wild type mice. A cystic mass was histologically confirmed as an
endometriotic lesion. (A) The number of lesions was counted
macroscopically. (B) All masses were resected. The weight (mg) per
lesion was measured. These data were compared between the fat-1 and
wild type (WT) mice (n=10 in each group). Mean values with standard
deviations are presented. Asterisks indicate those comparisons (fat-1 vs.
wild type mice) with statistical significance (p,0.05).
doi:10.1371/journal.pone.0073085.g001
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mice compared to the wild type. Among the EPA metabolites,
most difference in 12/15-hydroxyeicosapentaenoic acids (HEPE)
levels was observed (Fig. 2). As for DHA, there was no metabolite
showing a significant difference between fat-1 and wild type mice
(Fig. 2). In contrast, AA metabolites in fat-1 mice were generally
lower than those in the wild type mice (Fig. 2). Next, peritoneal
exudates were collected from the endometriosis-present peritoneal
cavity of fat-1 or wild type mice and were assessed for PUFA
metabolite profiles. Again, there was no difference in the amounts
of DHA metabolites between fat-1 and wild type mice (data not
shown). The main products derived from EPA and AA in
peritoneal cavity were shown in Fig. 3. Peritoneal fluids were
abundant in 12/15-HEPE in EPA metabolites and 12/15-
hydroxyeicosatetraenoic acids (HETE) in AA metabolites. The
amounts of 12/15-HEPE in fat-1 mice were significantly greater
than that in wild type mice, as shown in endometriotic lesions
(Fig. 3, center panel). Among AA metabolites, a significant
difference in the amounts of 12/15-HETE between fat-1 and wild
type mice was shown (Fig. 3, upper panel). These were the same
findings as those shown in endometriotic lesions. Taken together,
the increased amount of 12/15-HEPE was characterized markedly
in both the endometriotic lesions and peritoneal cells of fat-1 mice.
Endometriosis in the 12/15-LOX-KO mice
EPA-derived 12/15-HEPE was higher and AA-derived 12/15-
HETE was lower in the endometriotic lesions of fat-1 mice than of
those in wild type mice. Since both 12/15-HEPE and 12/15-
HETE are converted by 12/15-LOX, 12/15-LOX-related
mediators may play a role in protection against the development
of peritoneal endometriotic lesions. Then 12/15-LOX-KO and
wild type mice were administered EPA orally to address the effect
of 12/15-LOX-related mediators on endometriotic lesions by
comparing the number of the lesions with that of wild type mice.
Endometriotic lesions were generated in wild type and 12/15-
LOX-KO mice with or without EPA administration (n=4 in each
group) (Fig. 4). EPA administration decreased significantly the
number of endometriotic lesions in wild type mice. However, the
suppressive effect by EPA administration on the development of
endometriotic lesions was cancelled in 12/15-LOX-KO mice. In
12/15-LOX-KO mice with or without EPA administration, the
number of endometriotic lesions was the same level as that of wild
type mice with no administration.
Then we examined amounts of lipid mediators derived from
omega-3 as well as omega-6 PUFAs in the peritoneal fluids
obtained from wild type and 12/15-LOX-KO mice with or
without EPA administration (n=3 in each group) (Fig. 5). In wild
Figure 2. Lipid mediator analyses of endometriotic lesions: wild type vs. fat-1 mice. Endometriotic lesions obtained from fat-1 (white) or
wild type (WT: black) mice were assessed by lipidomic analyses (n=3 in each group). The main products of AA-, EPA- and DHA-derived mediators are
indicated. Y axis denotes the amount of each lipid mediator (pg/g sample). Mean values with standard deviations are presented. Asterisks indicate
those comparisons (fat-1 vs. wild type mice) with statistical significance (p,0.05).
doi:10.1371/journal.pone.0073085.g002
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significantly increased compared with wild type mice without EPA
administration. In comparison between wild type and 12/15-
LOX-KO mice with EPA administration, 12/15-HEPE was
significantly decreased in 12/15-LOX KO mice while PGE3 and
5-HEPE were almost equal amount between wild type and 12/15-
LOX-KO mice. Interestingly, EPA-derived bioactive mediators,
18S/R-resolvin E3 (RvE3) which is biosynthesized from 18-HEPE
by 12/15-LOX [27], was increased in peritoneal fluids of wild type
mice after EPA administration (Fig. 5, center panel). Again, the
increase of RvE3 was canceled in 12/15-LOX-KO mice. The
other E-series resolvins, RvE1 and RvE2, were negligible amounts
in both mice (data not shown). As for AA metabolites, there was no
difference in amounts of AA metabolites between wild type and
12/15-LOX-KO mice after EPA administration.
Comparison of expression profiles in endometriotic
lesions between fat-1 and wild type mice
In humans, the symptoms of endometriosis are thought to result
from an excessive inflammatory environment within the peritoneal
cavity. Elevated numbers of activated immune cells, including
macrophages, are involved in the production of inflammatory
cytokines. The expression profiles of endometriotic lesions in our
mice model were assessed using cDNA microarrays. A comparison
was made for the expression of the main cytokines between fat-1
and wild type mice and the ratio of fat-1/wild type for each
cytokine was indicated in Table 1 (n=3 in each group). Among
the cytokines examined, the IL-6 was the only one which was
reduced of a ratio greater than 0.5. Indeed, IL-6 expression in
endometriotic lesions of fat-1 mice was one fifth lower than that in
wild type mice.
Suppression of IL-6 mRNA production in peritoneal
macrophages in fat-1 mice
Peritoneal macrophages are one of the most important immune
cells to play a role in the development and progression of
endometriosis in the peritoneal cavity. Interestingly, peritoneal
macrophages possess 12/15-LOX abundantly and, in turn, 12/
15-LOX expressing cells are predominantly macrophages in the
peritoneal cavity in mice, while circulating and myeloid monocytes
do not express 12/15-LOX. We focused on peritoneal macro-
phages as a source of IL-6 and isolated macrophages from the
peritoneal cavity of fat-1 and wild type mice by CD11b-positive
selection. A comparison was made between the fat-1 and wild type
mice for IL-6 mRNA expression in peritoneal macrophages (n=5
in each group) (Fig. 6). IL-6 mRNA production in macrophages in
fat-1 mice was significantly suppressed by approximately one fifth
that of wild type mice.
Discussion
Numerous studies utilize fat-1 mice to examine the effects of
omega-3 PUFAs and the resultant anti-inflammatory mediators on
retarding inflammatory disease development and/or progression
to cancer. These models include LPS-induced hepatitis, dextrane
sodium sulfate (DSS)-induced colitis, and chronic colitis-associated
colon cancer [28–30]. Because it is possible to collect and analyze
peritoneal fluid, modified mice are particularly suitable for
Figure 3. Lipid mediator analyses of peritoneal fluids: wild type vs. fat-1 mice. Peritoneal exudates of mice developing endometriotic
lesions were collected by washing with saline. The peritoneal fluids obtained from the fat-1 (white) or wild type (WT: black) mice were analyzed as
shown in the Fig. 3 (n=3 in each group). The main products of AA-, EPA- and DHA-derived mediators are indicated. Y axis donates the amount of
each lipid mediator (pg/g sample). Mean values with standard deviations are presented. Asterisks indicate those comparisons (fat-1 vs. wild type
mice) with statistical significance (p,0.05).
doi:10.1371/journal.pone.0073085.g003
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models of endometriosis, because endometriosis is an intraperito-
neal disease. Fat-1 mice allow carefully controlled studies to be
performed in the absence of potential confounding factors of diet.
Here, fat-1 mice allowed us to investigate essential endogenously
biosynthesized mediators to suppress endometriotic lesions.
In this mouse model used in our experiment, cystic lesions were
formed as endometriotic lesions macroscopically. By counting the
number of them, and then excised them from surrounding normal
tissues, we could evaluate the suppressive effects on lesion
formation. In the results of this study, we could observe a
significant difference on lesion formation at the macroscopic level.
But some problems still remain. We could not evaluate and excise
exactly small and invisible lesions to the naked eye. For example, it
is sometimes difficult to distinguish small non-cystic lesions and
microscopic lesions from surrounding normal tissues. As a
solution, an animal model using green fluorescence protein
(GFP) mice may be useful in order to evaluate the small non-
cystic and microscopic lesions [21]. In this study, we used two
kinds of genetically modified mice, fat-1 and 12/15-LOX KO
mice. Because of some technical problems of mating, crossing, and
so on, it was not possible to use GFP mice in the same way as the
previous report in this study. But in our further research, the
introduction of GFP mice is expected to be useful for the
evaluation model of the effects on lesion formation.
Several previous studies have experimentally demonstrated the
suppressive effects of omega-3 PUFAs on endometriosis. Two
studies have used endometriosis animal models in which animals
were fed EPA [31] or fish oil [20] and another used human
endometrial stromal cells obtained from endometriosis patients
that were incubated with PUFAs in vitro [32]. All previous studies
on this field were not able to strictly address the mechanism or
lipid mediator by which endometriosis was suppressed. It is
difficult to make dietary components identical in both quality and
quantity when feeding animals an omega-3 PUFA-rich diet. In
animals administered purified EPA, the enrichment of EPA in the
animal organs should be transient. These methodologic limitations
may hamper identification of the biosynthesized mediators
responsible for the suppressive function against endometriosis.
When n-6/n-3 PUFAs levels become low, they prevent the
generation of pro-inflammatory eicosanoids from AA and convert
n-3 PUFAs into anti-inflammatory metabolites. As cellular level
mechanisms of anti-inflammatory effects, increased levels of n-3
PUFAs and their functional EPA or DHA-derived metabolites,
such as resolvins and protectins, help resolve inflammation mostly
through reductions, in neutrophils trafficking and upregulation of
macrophage-mediated removal of apoptotic cells [1]. For example,
when EPA-derived RvE1 interacts with BLT1, which is a receptor
expressed on neutrophils, pro-inflammatory signals from LTB4
are attenuated and LTB4-stimulated migration of neutrophils to
inflammatory sites is suppressed [5]. Moreover, when RvE1
interacts with ChemR23, which is a membrane receptor expressed
on macrophages, phagocytosis and transport to lymph nodes is
enhanced and the excessive activation of NF-kB is attenuated [4].
In patients with endometriosis, NF-kB expression is known to be
increased. NF-kB inhibitors have attracted attention as a novel
treatment in recent years [33,34]. These mechanisms indicated
that the suppressive effects of n-3 PUFAs and metabolites on
endometriosis may be related to attenuation of excessive NF-kB
activation.
In this study, global PUFA metabolite profiles in endometriotic
lesions and peritoneal cells were characterized by lipidomic
analyses between fat-1 and wild type mice. Analyses revealed that
12/15-HEPE were converted mainly from EPA in peritoneal
endometriosis and these amounts were approximately three-fold
larger in fat-1 mice than that in wild type mice. Increased 12/15-
HEPE amounts were observed similarly in both endometriotic
lesions and peritoneal exudates. This allowed us to focus on 12/
15-LOX-related mediator as a possible lipid mediator to suppress
endometriosis; 12/15-LOX-KO mice were then utilized to
address their suppressive effect on peritoneal endometriotic
lesions. In wild type mice, EPA administration protected against
the development of endometriotic lesions, consistent with the
results of a previous study [31]. This suggested EPA and/or any
EPA-derived mediators exhibit suppressive effect on the endome-
triotic lesions in fat-1 mice. Interestingly, the suppressive effect was
canceled in 12/15-LOX-KO mice although the mice were
administered EPA, suggesting that EPA itself may not have a
central effect on the development of endometriotic lesion. Our
lipid mediator analyses demonstrated that amounts of 12/15-
LOX-related metabolites such as 12/15-HEPE and RVE3 in wild
type mice were much larger than those in 12/15-LOX-KO mice
after EPA administration. RVE3 is recently identified as a novel
EPA-derived anti-inflammatory bioactive mediator which is
biosythesized from 18-HEPE via 12/15-LOX pathway [27].
Taken together, endometriotic lesions seem to be suppressed in a
manner dependent on 12/15-LOX pathway. EPA-derived 12/15-
LOX-related mediators may play a role in the protection effect in
this model.
Interestingly, more than 95% of murine peritoneal macrophag-
es express 12/15-LOX [35]. In turn, the predominant population
expressing 12/15-LOX is resident peritoneal macrophages in mice
[36]. Peritoneal macrophages are increased in number and more
activated in patients with endometriosis [37,38] and are one of the
major sources for inflammatory cytokines in the peritoneal cavity.
Therefore, peritoneal macrophages are thought to be involved in
Figure 4. Comparison of the number of endometriotic lesions
between wild type and 12/15-LOX-KO mice with or without
EPA administration. Endometriotic lesions were generated in wild
type (WT: black) and 12/15-LOX-KO (stripe) mice with or without oral
administration of 5% EPA ethyl ester. The number of endometriotic
lesions was compared between the wild type and 12/15-LOX-KO mice
with or without EPA oral administration (n=4 in each group). Mean
values with standard deviations are presented. Asterisks indicate those
comparisons with statistical significance (p,0.05).
doi:10.1371/journal.pone.0073085.g004
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PLOS ONE | www.plosone.org 6 September 2013 | Volume 8 | Issue 9 | e73085the development of endometriosis. The increased amounts of 12/
15-LOX-related EPA metabolites in the peritoneal exudates of fat-
1 mice may originate from peritoneal macrophages enriched in
omega-3 PUFA. The anti-inflammatory effect of EPA metabolites
may inhibit the development of peritoneal endometriotic lesions.
The decreased IL-6 mRNA levels in the peritoneal cells of fat-1
mice seem to reflect anti-inflammatory actions. One study
demonstrated that there were 1.7-fold more peritoneal macro-
phages in 12/15-LOX-KO mice than that in wild type mice and
Figure 5. Lipid mediator analyses of peritoneal fluids from wild type or 12/15-LOX-KO mice with or without EPA administration.
Peritoneal exudates of mice developing endometriotic lesions were collected by washing with saline. The peritoneal fluids obtained from mice as
shown in Fig. 5 were analyzed for lipid mediators (n=3 in each group). The main products of AA-, EPA- and DHA-derived mediators were indicated. Y
axis denotes the amount of each lipid mediator (pg/g sample). Mean values with standard deviations are presented. Asterisks indicate those
comparisons (wild type vs. 12/15-LOX-KO mice) with significance (p,0.05).
doi:10.1371/journal.pone.0073085.g005
Table 1. Comparison of the cytokine/chemokine profiles of
peritoneal endometriotic lesions between fat-1 and wild type
(WT) mice (n=3 in each group).
Cytokines fat-1/WT ratio
IL-6 0.2
TNF-a 0.6
TGF-b10 . 8
TGF-b20 . 6
IL-1b 0.7
IL-4 0.5
IL-10 0.5
IL-12b 1.0
IL-17a 0.9
doi:10.1371/journal.pone.0073085.t001
Figure 6. IL-6 production of peritoneal macrophages derived
from fat-1 and wild type mice. Peritoneal fluids were collected from
the fat-1 (white) and wild type (WT: black) mice as shown in Fig. 4 (n=5
in each group). Among them, peritoneal macrophages were isolated by
CD11b-beads selection. IL-6 mRNA levels in isolated macrophages were
measured by RT-quantitative PCR. IL-6 mRNA levels were normalized to
b-actin. Mean values with standard deviations are presented. Asterisks
indicate those comparisons (fat-1 vs. wild type mice) with statistical
significance (p,0.05).
doi:10.1371/journal.pone.0073085.g006
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PLOS ONE | www.plosone.org 7 September 2013 | Volume 8 | Issue 9 | e73085that the 12/15-LOX pathway exerted negative effects on
monocyte/macrophage migration into the peritoneal cavity [39].
This decrease may be favorable for protection against the
development of endometriotic lesions in 12/15-LOX-KO mice.
In this study, we showed the suppressive effect of omega-3
PUFAs in the mouse endometriosis model by making full use of
two types of genetically modified mice: fat-1 and 12/15-LOX KO
mice. To take sufficient amounts of omega-3 PUFAs, we need to
eat a lot of fish and fish oil or EPA supplements. However, there
are limitations to the amount of sufficient omega-3 PUFAs intake,
so we think it is desirable that we identify more effective
metabolites than omega-3 PUFAs themselves. We revealed the
function of key metabolites in the suppressive mechanism by using
lipidomic analysis. Further research will provide more insight into
the effects of omega-3 PUFAs and possibly lead to the treatment
for endometriosis involving novel anti-inflammatory mediators.
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